Skip to content
Register Sign in Wishlist
Look Inside Progress in Neurotherapeutics and Neuropsychopharmacology

Progress in Neurotherapeutics and Neuropsychopharmacology

Volume 2. 2007

$79.00 (G)

Jeffrey L. Cummings, Rianne A. J. Esselink, Rob M. A. de Bie, Rob J. de Haan, P. Richard Schuurman, Pepijn van den Munckhof, Johannes D. Speelman, Bernard Ravina, Yuko Palesch, Encarnita Raya-Ampil, Kimford J. Meador, Zerife Sahenk, Tobey J. MacDonald, Antonio M. P. Omuro, Joachim Yahalom, Lauren E. Abrey, F. E. Taragano, P. M. Bagnati, R. F. Allegri, Tung-Ping Su, Chih-Chia Huang, Robert S. Kern, Michael F. Green, Stephen R. Marder, Anna Lembke, Charles DeBattista, David E. Kemp, Keming Gao, David J. Muzine, Prashant Gajwani, Joseph R. Calabrese, Srihari Gopal, John L. Beyer, David C. Steffens, Michelle L. Kramer, Mauricio Tohen, Daniel Yen Lin, Mauricio Silva de Lima, Alan Breier, Jair de Jesus Mari, Lisa A. Marsch
View all contributors
  • Date Published: July 2012
  • availability: Available
  • format: Paperback
  • isbn: 9781107405806

$ 79.00 (G)
Paperback

Add to cart Add to wishlist

Other available formats:
Hardback


Looking for an examination copy?

If you are interested in the title for your course we can consider offering an examination copy. To register your interest please contact collegesales@cambridge.org providing details of the course you are teaching.

Description
Product filter button
Description
Contents
Resources
Courses
About the Authors
  • Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists.

    • Annual update on clinical trials in neurotherapeutics and psychopharmacology
    • Editor, editorial board and contributors are all leading international figures
    • Provides the evidence on which to base treatments
    • Essential resource for clinicians and neuroscientists
    Read more

    Customer reviews

    Not yet reviewed

    Be the first to review

    Review was not posted due to profanity

    ×

    , create a review

    (If you're not , sign out)

    Please enter the right captcha value
    Please enter a star rating.
    Your review must be a minimum of 12 words.

    How do you rate this item?

    ×

    Product details

    • Date Published: July 2012
    • format: Paperback
    • isbn: 9781107405806
    • length: 284 pages
    • dimensions: 244 x 170 x 15 mm
    • weight: 0.46kg
    • availability: Available
  • Table of Contents

    1. Progress in Neurotherapeutics and Neuropsychopharmacology 2007 Jeffrey L. Cummings
    2. A randomized trial comparing unilateral pallidotomy with bilateral subthalamic nucleus stimulation in PD: perspectives for future implication in clinical practice Rianne A. J. Esselink, Rob M. A. de Bie, Rob J. de Haan, P. Richard Schuurman, Pepijn van den Munckhof and Johannes D. Speelman
    3. The phase II futility clinical trial design Bernard Ravina and Yuko Palesch
    4. Clinical trials in dementia Encarnita Raya-Ampil and Jeffrey L. Cummings
    5. Comparative neuropsychological effects of Lamotrigine and Topiramate in healthy volunteers Kimford J. Meador
    6. Pilot clinical trial of NT-3 in CMT1A patients Zerife Sahenk
    7. New directions in pediatric neuro-oncology practice: impact of the Children's Cancer Group Study 9933, a phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma Tobey J. MacDonald
    8. Chemoradiotherapy for primary CNS lymphoma Antonio M. P. Omuro, Joachim Yahalom and Lauren E. Abrey
    9. A double-blind, randomized clinical trial to assess the augmentation with Nimodipine of antidepressant therapy in the treatment of 'vascular depression' F. E. Taragano, P. M. Bagnati and R. F. Allegri
    10. Repetitive transcranial magnetic stimulation: a novel, noninvasive add-on treatment for medication-resistant depression Tung-Ping Su and Chih-Chia Huang
    11. The NIMH MATRICS initiative: development of a consensus cognitive battery Robert S. Kern, Michael F. Green and Stephen R. Marder
    12. Review of a randomized controlled trial of adjunctive Bupropion in the treatment of SSRI-induced sexual dysfunction Anna Lembke and Charles DeBattista
    13. Trial-based advances in the treatment of bipolar depression David E. Kemp, Keming Gao, David J. Muzine, Prashant Gajwani and Joseph R. Calabrese
    14. Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of Risperidone monotherapy Srihari Gopal, John L. Beyer, David C. Steffens and Michelle L. Kramer
    15. Olanzapine as maintenance therapy in patients with bipolar I disorder Mauricio Tohen and Daniel Yen Lin
    16. Can quality of life be improved in schizophrenia? Results from a pragmatic, randomized controlled trial comparing Olanzapine with first generation antipsychotics Mauricio Silva de Lima, Alan Breier and Jair de Jesus Mari
    17. Combined behavioral and pharmacological treatment of opioid-dependent adolescents: a randomized, controlled trial Lisa A. Marsch.

  • Editor

    Jeffrey L. Cummings, Cleveland Clinic Lou Ruvo Center for Brain Health

    Contributors

    Jeffrey L. Cummings, Rianne A. J. Esselink, Rob M. A. de Bie, Rob J. de Haan, P. Richard Schuurman, Pepijn van den Munckhof, Johannes D. Speelman, Bernard Ravina, Yuko Palesch, Encarnita Raya-Ampil, Kimford J. Meador, Zerife Sahenk, Tobey J. MacDonald, Antonio M. P. Omuro, Joachim Yahalom, Lauren E. Abrey, F. E. Taragano, P. M. Bagnati, R. F. Allegri, Tung-Ping Su, Chih-Chia Huang, Robert S. Kern, Michael F. Green, Stephen R. Marder, Anna Lembke, Charles DeBattista, David E. Kemp, Keming Gao, David J. Muzine, Prashant Gajwani, Joseph R. Calabrese, Srihari Gopal, John L. Beyer, David C. Steffens, Michelle L. Kramer, Mauricio Tohen, Daniel Yen Lin, Mauricio Silva de Lima, Alan Breier, Jair de Jesus Mari, Lisa A. Marsch

Sign In

Please sign in to access your account

Cancel

Not already registered? Create an account now. ×

Sorry, this resource is locked

Please register or sign in to request access. If you are having problems accessing these resources please email lecturers@cambridge.org

Register Sign in
Please note that this file is password protected. You will be asked to input your password on the next screen.

» Proceed

You are now leaving the Cambridge University Press website. Your eBook purchase and download will be completed by our partner www.ebooks.com. Please see the permission section of the www.ebooks.com catalogue page for details of the print & copy limits on our eBooks.

Continue ×

Continue ×

Continue ×

Find content that relates to you

Join us online

This site uses cookies to improve your experience. Read more Close

Are you sure you want to delete your account?

This cannot be undone.

Cancel

Thank you for your feedback which will help us improve our service.

If you requested a response, we will make sure to get back to you shortly.

×
Please fill in the required fields in your feedback submission.
×